{"bill": {"#text": "\n  ", "form": {"current-chamber": {"#tail": "\n    ", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n", "congress": {"#tail": "\n    ", "#text": "113th CONGRESS"}, "#tail": "\n  ", "legis-num": {"#tail": "\n    ", "#text": "H. R. 3303"}, "official-title": {"#tail": "\n  ", "#text": "To amend the Federal Food, Drug, and Cosmetic Act to provide for regulating medical software, and for other purposes."}, "session": {"#tail": "\n    ", "#text": "1st Session"}, "distribution-code": {"#tail": "\n    ", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n      ", "@date": "20131022", "#text": "October 22, 2013"}, "#tail": "\n    ", "action-desc": {"#tail": "\n    ", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, "sponsor": {"#tail": " (for herself, ", "#text": "Mrs. Blackburn", "@name-id": "B001243"}, "cosponsor": [{"#tail": ", ", "#text": "Mr. Gene Green of Texas", "@name-id": "G000410"}, {"#tail": ", ", "#text": "Mr. Walden", "@name-id": "W000791"}, {"#tail": ", ", "#text": "Ms. DeGette", "@name-id": "D000197"}, {"#tail": ", and ", "#text": "Mr. Butterfield", "@name-id": "B001251"}, {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Mr. Gingrey of Georgia", "@name-id": "G000550"}]}, "#text": "\n      "}, "legis-type": {"#tail": "\n    ", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "HC2A0CB359D834018BB4C12AF754A26E8", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n    ", "quote": [{"short-title": {"#tail": "\n        ", "#text": "Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013"}, "#tail": " or the ", "#text": "\n          "}, {"short-title": {"#tail": "\n        ", "#text": "SOFTWARE Act of 2013"}, "#tail": ".", "#text": "\n          "}], "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "HE650ACD280F6466F908F42DFB877D87A"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Medical software"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 201 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:201"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 321", "@value": "usc/21/321"}, "@parsable-cite": "usc/21/321", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Definition of medical software"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n      ", "subsection": {"#tail": "\n          ", "text": {"#tail": "\n            ", "term": {"#tail": " means software that is intended for human or animal use and\u2014", "#text": "medical software"}, "#text": "The term "}, "enum": {"#tail": "\n            ", "#text": "(ss)"}, "paragraph": [{"#tail": "\n            ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "is intended to be marketed to directly change the structure or any function of the body of man or other animals; or"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@display-inline": "yes-display-inline", "#text": "\n                ", "@id": "H9EF7EDBF658B4079852AEBF76C81229F", "@commented": "no"}, {"@indent": "up1", "#tail": "\n            ", "text": {"#tail": "\n                ", "#text": "is intended to be marketed for use by consumers and makes recommendations for clinical action that\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "includes the use of a drug, device, or procedure to cure or treat a disease or other condition without requiring the involvement of a health care provider; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "HA89B583EF7514A4D93FFCCB5DD5E9EFB", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "#text": "if followed, would change the structure or any function of the body of man or other animals;"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "H991F95DA836D410CB294E236E884D09B", "#text": "\n                  "}], "#text": "\n                ", "@id": "HBC53AE372B7148F0A73E8B84C9AAA9D3"}], "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "HACA2C376C6844A14BF602F6E5E4641F1", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "is not software whose primary purpose is integral to the functioning of a drug or device; and"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@id": "H494466C7E4DF4274993A4CFAA400687A", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "#text": "is not a component of a device."}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "@id": "H6310EFB0340E4DD6B6DA87F010C47DD6", "#text": "\n              "}], "#text": "\n            ", "@id": "H7326C19FEAA447C68802DE9CAD8CC31E"}, "#text": "\n          ", "@id": "H52FE35D6E443423EA4D59946997C18B5"}, "#text": "\n        ", "@id": "H47DCE4F0676B476EA992C1BB38C5EF96"}, {"#tail": "\n    ", "text": {"#tail": "\n        ", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Subchapter A of chapter V of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V/sch:A"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 351 et seq.", "@value": "usc/21/351/etseq"}, "@parsable-cite": "usc/21/351", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Regulation"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n      ", "section": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "524B."}, "header": {"#tail": "\n            ", "#text": "Medical software"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "The provisions of this Act shall apply with respect to medical software to the same extent and in the same manner as such provisions apply with respect to devices."}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "In general"}, "#text": "\n              ", "@id": "HA7CA86A123744CBB92D3A597DCD2AEBD"}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall delegate primary jurisdiction for regulating medical software to the center at the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "1200"}, {"#tail": " charged with regulating devices.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n              ", "#text": "Delegation"}, "#text": "\n              ", "@id": "HCDE1AC3C94C3430BA40C8B278E616D0F"}], "#text": "\n            ", "@id": "HCEBB1733287543E993D774748FE3890D"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "H49D7FB46344C4048B45F3ABB70CC13C4"}, "#text": "\n        ", "@id": "H093BA840286448F3B8081F94AFB552F0"}], "#text": "\n      ", "@id": "H1F6C3BB69EC4477688C29F52825DC626"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Clinical software and health software"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", is further amended by adding at the end the following:", "@entity-type": "act", "#text": "section 2(a)", "@value": "Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013/s:2/ss:a", "@proposed": "true"}, "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", as amended by ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 201 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:201"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 321", "@value": "usc/21/321"}, "@parsable-cite": "usc/21/321", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Definitions"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n      ", "subsection": {"#tail": "\n          ", "#text": "\n            ", "enum": {"#tail": "\n            ", "#text": "(tt)"}, "@id": "H6EF4DF95515F40F98EBAAEB684E7B296", "paragraph": [{"@id": "HACBCF4EE9735420585B8E9546CAD8E15", "#tail": "\n            ", "text": {"#tail": "\n              ", "term": {"#tail": " means clinical decision support software or other software (including any associated hardware and process dependencies) intended for human or animal use that\u2014", "#text": "clinical software"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@display-inline": "yes-display-inline", "#text": "\n              ", "subparagraph": [{"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "captures, analyzes, changes, or presents patient or population clinical data or information and may recommend courses of clinical action, but does not directly change the structure or any function of the body of man or other animals; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "#text": "\n                ", "@id": "H11E712252B2444DE9B9A83C42CE1195A"}, {"@indent": "up1", "#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "is intended to be marketed for use only by a health care provider in a health care setting.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "#text": "\n                ", "@id": "H7A841109199E4D0482D1CDC6538EE4FA"}], "@commented": "no"}, {"@indent": "up1", "#tail": "\n          ", "text": {"#tail": "\n              ", "term": {"#tail": " means software (including any associated hardware and process dependencies) that is not medical software or clinical software and\u2014", "#text": "health software"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "#text": "\n              ", "@id": "H958DB500F88C45CB9B87F89B8A52C3BB", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "that captures, analyzes, changes, or presents patient or population clinical data or information;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H745B7C2519814B89A608A2ACA12938FF", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "that supports administrative or operational aspects of health care and is not used in the direct delivery of patient care; or", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H37D407F02AE549FE81B87B97E0E4D7AC", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "whose primary purpose is to act as a platform for a secondary software, to run or act as a mechanism for connectivity, or to store data.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "HC79BC1D06EE44AD594529D1233B44001", "#text": "\n                "}]}]}, "#text": "\n          ", "@id": "H65E50991137E47CC95D0B0B7ABC89719"}, "#text": "\n        ", "@id": "HC04552F940384861BDA6480A58589778"}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", is further amended by adding at the end the following:", "@entity-type": "act", "#text": "section 2(b)", "@value": "Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013/s:2/ss:b", "@proposed": "true"}, "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", as amended by ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Subchapter A of chapter V of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V/sch:A"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 351 et seq.", "@value": "usc/21/351/etseq"}, "@parsable-cite": "usc/21/351", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Prohibition"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n      ", "section": {"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "Clinical software and health software shall not be subject to regulation under this Act.", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n            ", "#text": "524C."}, "header": {"#tail": "\n            ", "#text": "Clinical software and health software"}, "#text": "\n            ", "@id": "HFF7A1EF1351346C0A0810B972977E863"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "H255ADF25ED3446B59ECF3F5A075CF2AF"}, "#text": "\n        ", "@id": "HED3C780B154D4A5BBB1311BE87DBDC8F"}, {"#tail": "\n    ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that\u2014", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, "#text": "It is the sense of the "}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Sense of Congress"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as added by ", "@entity-type": "act", "#text": "section 201(tt) of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:201/ss:tt", "@proposed": "true"}, {"#tail": ")\u2014", "@entity-type": "act", "#text": "subsection (a)", "@value": "Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013/s:3/ss:a", "@proposed": "true"}], "#text": "clinical software and health software (as defined in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "#text": "\n          ", "@id": "H1A7C2FCAC3B34094B87561243F072CDD", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "advance the goals of enhanced patient safety and continued innovation;"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H74A8733332DF47718B8FB6DE550189DF", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "hold much promise to lower costs and improve the health of patients; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H2FEFF604694D4007978A2C2F30B966F1", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "can improve the quality and efficacy of health care provider services; and"}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "@id": "H45CB7606F98E43528C8285BD4B3E9ACF", "#text": "\n            "}]}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and the ", "@entity-type": "federal-body", "#text": "President", "@entity-id": "1100"}, {"#tail": " should work together to develop and enact legislation that establishes a risk-based regulatory framework for such clinical software and health software that reduces regulatory burdens, promotes patient safety, and fosters innovation.", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}], "#text": "the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "HC6173FB522D248F1940F1EE6F85F934F", "#text": "\n          "}], "#text": "\n        ", "@id": "HEA2FE09BCD974815A9258A9D61227D0E"}], "#text": "\n      ", "@id": "HCD0B3ACEB7004610BA79B0DF5D2A801C"}, {"#tail": "\n  ", "text": {"#tail": "\n      ", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 201(h) of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:201/ss:h"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 321", "@value": "usc/21/321"}, "@parsable-cite": "usc/21/321", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n      ", "#text": "Exclusion from definition of device"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking ", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:201/ss:h/p:2"}, "#text": "in ", "quote": [{"short-title": {"#tail": "\n          ", "#text": "or other animals, or"}, "#tail": " and inserting ", "#text": "\n            "}, {"short-title": {"#tail": "\n          ", "#text": "or other animals,"}, "#tail": ";", "#text": "\n            "}]}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "HA68A3F9060E04B7FBF597D8D8BFD527E", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking ", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:201/ss:h/p:3"}, "#text": "in ", "quote": {"short-title": {"#tail": "\n          ", "#text": "and"}, "#tail": "; and", "#text": "\n            "}}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "H476926064B6846A78B3F6386F1C272B7", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " the following new paragraphs:", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:201/ss:h/p:3"}, "#text": "by inserting after "}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n      ", "paragraph": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "is not medical software, or", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(4)"}, "@id": "HFFCC5FFBE3914B059331B2C72E4D21AF", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "is not clinical software or health software, and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(5)"}, "@id": "H75E228E03C784978BD656412048564EC", "#text": "\n            "}], "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "H70983CEDE77D434F9D96F19421E1A017"}, "#text": "\n        ", "@id": "HF802F74E682C4A58AFC9799C18F8263B"}], "#text": "\n      ", "@id": "H7538C9872189467DB904AD87EEB20300"}], "#text": "\n    ", "@id": "HFD1C1E4759E84058895E0CC74D32A7FC"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-10-22"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 3303 IH: Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}